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Abstract
Ancient Egyptian human remains have been of interest in 
the fields of both medical and Egyptological research for de-
cades. However, canopic jar holders for internal organs (liver, 
lungs, stomach, intestines) of Egyptian mummies appear to 
be but a very occasional source of data for such investiga-
tions. The few medical approaches focusing on the content 
of these jars are summarized and listed according to patho-
gens and diseases to give a structured overview of this field 
of study. An extensive search of the literature has been con-
ducted from different bibliographic databases with a total of 
n = 26 studies found. The majority of diseases found con-
sisted of infectious diseases and internal medicine condi-
tions such as schistosomiasis or emphysema. These are just 
2 examples of many that, instead of primarily affecting bone, 
muscle or skin, specifically target internal organs. Hence, a 
better understanding of the evolution of diseases that still 
affect mankind could be gained. In conclusion, this reassess-
ment shows that canopic jars represent a highly underesti-
mated source for histological, radiological and ancient DNA 
examination of Ancient Egyptian remains and should, thus, 
be more and more brought back into the focus of retrospec-
tive medical research. © 2018 S. Karger AG, Basel
Introduction
“Canopic jars” represent viscera containers of Ancient 
Egyptian mummies: because of their various forms and 
shapes they ought to be more appropriately referred to as 
“canopic equipment” [1]. During the 4th Dynasty (Old 
Kingdom, ca. 2600 BC), the first canopic containers and 
jars were developed, each containing a specific internal 
organ, namely, liver, lung, stomach and intestine [2]. 
During the 8th Dynasty, at the beginning of the First In-
termediate Period (ca. 2200–2000 BC), the design devel-
oped into 4 jars with human heads, representing the 4 
children of Horus. In the Ramesside Period of the New 
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Kingdom (19th Dynasty, ca. 1300 BC), the heads changed 
to the iconic layout with one human head (Amset), a ba-
boon (Hapy), a jackal (Duamutef) and a falcon (Qebekh-
senuef). Even in the New Kingdom, when the tradition of 
using canopics reached a peak, following local traditions, 
bodies were mummified without removing the viscera or 
the brain, for example, Kha and Merit in Deir el-Medina 
(mid-18th Dynasty, ca. 1350 BC) [3]. The range of mum-
mification methods is much broader than is generally be-
lieved [4]. The disappearance of the funerary practice of 
placing organs into canopic jars can be observed from the 
Roman Period (ca. 30 BC–350 AD) not only because of a 
lack of technical embalming skills but also on account of 
a new focus on the mummy portrait and elaborate wrap-
ping. Thus mummies’ viscera became gradually less im-
portant and were left in situ [1, 4, 5]. Since a great number 
of pathogens and diseases have their main localization in 
visceral body districts, preserved internal organs from 
Ancient Egypt can be considered to have significant med-
ical interest. Radiological, histological as well as ancient 
DNA analysis of embalmed viscera may reasonably yield 
new information about the actual presence, phenotype 
and genotype of diseases in ancient times, thus leading to 
a better understanding of their evolution and historical 
trends [6, 7]. Compared to the high number of publica-
tions on mummies, only few approaches aimed at deter-
mining diseases in ancient internal organs have been pro-
duced. The purpose of this article is to offer an overview 
of pathogens and diseases found in canopic jars. The ap-
proach adopted here consists of reviewing the available 
literature on the topic by offering a detailed overview of 
the major pathological results obtained for biomedical re-
search over the past decades. At the secondary level, this 
article endeavours to suggest novel approaches and high-
light key scientific questions to be addressed by future 
palaeopathological and bioarchaeological research.
Material and Methods
An extensive online search was performed in the platforms 
PubMed, Google Scholar, ScienceDirect, and Rechercheportal 
(online library of the University of Zurich, Zurich, Switzerland) 
using the non-MESH terms “canopics,” “canopic equipment,” 
“canopic jars,” complemented with more medically and biologi-
cally oriented entries such as “mummy” and “mummies.” Further-
more, the terms “viscera,” “remains,” “soft tissue” and “internal 
organs” and more specifically “liver,” “lungs,” “stomach” and “in-
testines” were looked up in combination with the above-listed 
terms. The online search was enriched via a traditional research in 
conventional libraries (e.g., Zentralbibliothek and the Library of 
Egyptology, University of Zurich, Zurich, Switzerland) on the sub-
jects of mummies and mummified internal organs. After gaining 
background information on the topic, the investigation started fo-
cusing on the different diseases reported in Ancient Egyptian hu-
man remains, which in turn yielded additional bibliographical ref-
erences. One of the key criteria was finding references specifically 
and solely about Egyptian mummified bodies. This choice exclud-
ed all publications about mummies from other geographical loca-
tions. In later dynasties – besides extracorporeal canopic jars – in-
tracorporeal embalmed viscera packages existed (i.e., left inside the 
emptied body cavity of the mummy): these embalming options 
have also been included in this study. As an additional method-
ological note, it should be remarked, that although the dramatic 
technological development makes the most recent publications of 
higher scientific value, the large quantity of much earlier publica-
tions, albeit drawing on not so advanced techniques, has equally 
proved of interest for the present assessment. Finally, in order to 
better contextualize the discussed pathologies, a historical search 
of their first recognized scientific description has been performed. 
Results
N = 26 publications from 4 different databases were 
found to be matching the above listed criteria and were 
thus considered to be of interest for this research. The fol-
lowing results were presented according to the system af-
fected by the pathological process, while parasitic infec-
tions have been grouped irrespective of the targeted or-
gan or system.
Parasitic Infections
Schistosomiasis
This disease was first described by Theodor Bilharz 
(1825–1862) during an autopsy in 1851, hence its original 
eponym bilharziosis [8]. One of the investigators to focus 
on the rehydration of soft tissue samples from Egyptian 
mummies back to a status – despite the obvious limita-
tions – comparable to the time before death was Marc A. 
Ruffer (1859–1917), the founder of modern palaeopa-
thology. He was the first to describe calcified eggs of Schis-
tosoma haematobium in Egyptian mummies [9]. The par-
asite infested the body via the intact skin or was ingested. 
Ruffer found the calcified eggs in the kidneys of 2 mum-
mies of the 20th Dynasty. Later studies found eggs of 
Schistosoma haematobium in Egyptian mummies, such as 
the Royal Ontario Museum I mummy (ROM I), where 
not only eggs but also potential alterations in the hepatic 
architecture were observed [10]. Scientists conducting 
the autopsy of ROM I found schistosomal eggs penetrat-
ing the muscular layers of the small and large intestines, 
the bladder and also infestation of the portal areas com-
bined with signs of early cirrhosis, thus suggesting fibrot-
ic response as a result of an infection by Schistosoma. 
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They also found calcified eggs without terminal spines, 
which are typically for S. mansoni (another subspecies); 
therefore, they supposed that it could not be S. haemato-
bium. Nonetheless, it is interesting to note that both 
forms are endemic in Egypt nowadays, and the possibil-
ity of a co-infection should be taken into account [11]. 
Leishmaniasis
These subspecies morphologically appear in 3 different 
forms: visceral, cutaneous and mucocutaneous when 
transmitted from sand flies (Phlebotomidae) to humans. It 
is believed that cutaneous forms were already mentioned 
in Ebers Papyrus (ca. 1550 BC), as “Nile Pimple.” The cu-
taneous disease has long been long well known in the Arab 
world as well as in Africa, Central Asia and South America. 
Arab scientists had different names for the disease until 
1885, when Cunningham first identified the parasite and 
Lühe named it Leishmania tropica in 1906, a name still 
used today. In 1911, Vianna attributed the recently discov-
ered mucocutaneous disease in South American areas to a 
new species of the pathogen named Leishmania brazilien-
sis [12]. In 1903, Ross was the first to introduce the term 
Leishmania donovani after the parasite was isolated at the 
same time by William Leishman and the Irish physician 
Charles Donovan, independently from one another [13]. 
Visceral leishmaniasis is of special interest to canopic jar 
research, since it affects internal organs like the liver, heart, 
spleen or kidneys. Zink et al. [14] found 4,000-year-old L. 
donovani DNA from bone tissue after amplification via 
PCR proving that visceral leishmaniasis was indeed pres-
ent in Ancient Egypt. However, all the mummies affected 
with leishmaniasis came from the Middle Kingdom, and 
therefore no general statement about earlier and later pe-
riods could be made.
Cysticercosis
Filled vesicles of Taenia were first observed in the cor-
pus callosum of a man died of a stroke by Domenico 
Paranolo in 1550 [15]. The first correct description of T. 
solium and T. saginata were made by Linnaeus [16] (1707–
1778) in 1758 and Goeze [17] (1731–1793) in 1782 respec-
tively. However, the disease cysticercosis was first discov-
ered in pigs by Hartmann in 1688. The eggs of the 2 tape-
worms T. solium or T. saginata may be similar in shape, 
but they are different in their clinical appearance. Reyman 
et al. [11] pointed out that during the investigation of Na-
kht (ROM I), whose intestinal tissue had been sampled, 
numerous eggs of Taenia spp. were found but they could 
not be further differentiated into T. solium and T. saginata. 
Bruschi et al. [18] were able to distinguish between the 2 
forms of infection caused by the parasite. The mummy 
they investigated dated to the Ptolemaic period and was of 
young age at the time of death. The female individual was 
mummified and the organs were extracted, embalmed and 
put back into the body’s cavity. The immunohistochemical 
analysis of a macroscopically visible cystic lesion of the 
stomach wall demonstrated the presence of T. solium.
Trichuris 
One of the most common parasitic infections in the 
world is the infestation by Trichuris trichiura, especially 
where access to clean drinking water is scarce and general 
supply is poor. The first to locate these parasites in the 
caecum and transverse colon was Morgagni [19] (1682–
1771) in 1740 followed by more precise morphological de-
scriptions by Roederer [20] in 1761 and finally classified 
as nematode by Linnaeus [21] in 1771 [22]. The resulting 
disease is often asymptomatical, but it can exacerbate into 
haemorrhagic inflammation of the colon. Bouchet et al. 
[23] provided evidence of Trichuris eggs found in canopic 
jars from natural mummified individuals ranging from 
2400 BC to 1500 AD suspecting that the infection oc-
curred in Egypt due to the intensive trade with Nubians. 
The canopic jar containing the parasite’s eggs are from the 
New Kingdom (18th–20th Dynasty) [24].
Ascaris
During the autopsy of PUM II (Pennsylvania University 
Mummy) by Cockburn et al. [25], a single egg of helminthic 
nature was detected in the intestinal tissue. After examin-
ing the specimen, the conclusion was that it was the round-
worm Ascaris, most probably A. lumbricoides [25]. The 
parasite was anatomically described by Tyson [26] (1650–
1708) in 1683 before Linnaeus [27] gave it its currently 
known name in 1758. A significant overview of the life cycle 
was given by Ransom and Foster [28]. The larvae of this 
parasite first infest the intestinal tract, and then migrate 
through the wall of the intestine to the liver, lungs and in a 
retrograde manner, via the trachea, again to the intestinal 
tract. This means that during the larval stage in humans, the 
parasite could be visible in lung, liver or stomach tissue and 
therefore, findings in canopic jars would not be surprising. 
Respiratory System 
Bronchopneumonia and Pulmonary Oedema
Hippocrates (460–377 BC) provided the first detailed 
definition of the disease although realistically it had al-
ready been known since long before. He introduced the 
term “peripneumonia” and described its symptoms [29]. 
In 1881, the bacterial pathogen Streptococcus pneumoni-
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ae, found to be the causative agent of pneumonia, was 
isolated independently by Pasteur [30] (1822–1895) and 
Sternberg [31] (1838–1915). The definition of pulmonary 
oedema in a medical sense first emerged in 1819 when 
Laënnec described it as “an infiltration of serum into the 
pulmonary tissue, carried to a degree such that it signifi-
cantly diminishes its permeability to air” [32, 33]. Look-
ing at histological specimens of lung tissue, an exudate 
consisting of a mix of fibrin, protein and granulocytes can 
be clearly seen, whereas the structure/scaffold of the lung 
remains mostly intact. These findings were first reported 
in mummified lungs by Shaw [34] in 1938 and in subse-
quent investigations, such as that by Walker et al. [35] in 
1987, showed bronchopneumonia with fibrinous or pro-
teinaceous exudate despite the fact that the alveolar struc-
ture remained normal. Walker et al. [35] even suggested 
that in 2 of the 6 investigated lung tissue samples from 
embalmed viscera, the pneumonia and pulmonary oede-
ma led to respiratory failure and subsequently to death. 
Shaw [34] examined the corpse and internal organs of the 
mummy of Har-mose (18th Dynasty, New Kingdom, ca. 
1490 BC), in whose grave lay a wooden box placed at his 
feet, which contained the preserved viscera, namely, lung, 
liver with gall bladder, mesenterial and intestinal tissue. 
The researchers considered acute bronchopneumonia 
and pleurisy as the most probable cause of death. This was 
supported by a sample of the lower lobe of the lung stained 
with the van Gieson method, which led to the retrospec-
tive diagnosis of acute bronchopneumonia [35]. 
Emphysema
It was the French physician René Laënnec (1781–1826) 
who originally reported the pathology of pulmonary em-
physema separately from chronic bronchitis and asthma 
in 1819 [36, 37]. A case of emphysema of the lungs was 
shown during the autopsy of the Egyptian mummy Har-
mose. The coffin, at the mummy’s feet, contained viscera 
among which lungs, which were subjected to histological 
examination. Macroscopically, the 3 lobes of the right 
lung were well distinguishable and the middle lobe con-
sisted of “emphysematous air sacs,” as well as the anterior 
border of the lower lobe below the apex that contained a 
“subpleural emphysematous bulla” of the size of 0.5 cm. 
It was noted that the middle lobe was filled with so much 
air that it floated in water, whereas the lower lobe did not. 
The alveolar structure of the upper lobe was normal, 
while the alveolar walls of the middle lobe were weakened 
and thinned as a result of the abnormal condition of em-
physema [35]. Another investigation on lung tissue from 
Ancient Egyptian mummies by Walker et al. [34] focused 
on the remains of Henutmehyt (19th Dynasty New King-
dom). The researchers came to the conclusion that one of 
the 6 examined samples showed an abnormal alveolar 
structure in agreement with “focal centriacinar/lobular 
emphysema.” The specimens were extracted from 3 
canopic jars, one canopic coffin and 2 bundles of em-
balmed viscera found in the chest cavity [38]. 
Pneumoanthracosis and Silicosis
Already in the 16th century it had been observed that 
miners had a short breath and often died of a premature 
death, which could be traced back to the inhalation of the 
dust during work [39]. Describing the effect of the envi-
ronment of mine workers, Bernardino Ramazzini (1633–
1714) wrote in 1705: “Thus far I have given an Account 
of such workmen as are thrown into various diseases by 
the Malignity of the Minerals and Fossils that they handle 
and use in the way of their business” [as quoted in 40]. 
This was followed by the first use of the term “pneumo-
coniosis” by Zenker [41] (1825–1898) in 1867. In the field 
of palaeopathology it was Ruffer [42] who noted the pres-
ence of signs of diffuse anthracosis in the lungs of a 20th-
dynasty mummy. He discovered “jet black or dark yellow 
material” in alveolar spaces and interstitia reaching deep 
into the tissue with the only possible diagnosis of anthra-
cosis. The reason for this was related to the use of indoor 
fire and professions involving working in dust- and 
smoke-rich air. Whether the continuous exposure to 
small air-floating particles could have had an impact on 
life condition in Ancient Egypt, thus enhancing the prob-
ability of other lung diseases or whether it occurred natu-
rally asymptomatically, is subject to further discussion. In 
1940, Shaw [34] noticed anthracosis in the 3,500-year-old 
Egyptian mummy next to severe emphysema and bron-
chopneumonia. Especially the interlobular septa of the 
upper and lower lobes of the right lung found in the 
canopic coffin were affected, yet not the middle lobe 
which was marked with emphysematous bullae. A closer 
look revealed many black masses next to the bronchi and 
their bifurcation, leaving no doubt that those were mac-
roscopically visible anthracotic lymph nodes. Few de-
cades later, Reyman et al. [11] discovered anthracotic pig-
ment during the autopsy of Nakht (ROM I) notably in the 
connective tissue of the lung. They even found “bright 
birefringent particles,” which they thought to be silica, 
but after using X-ray diffraction analysis and electron mi-
croscopy, they regarded them as granite particles. The 
first description of sand silicosis in Ancient Egyptian re-
mains, however, is to be found in Cockburn et al. [10] and 
Tapp et al. [43] work. Sand pneumoconiosis is mentioned 
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during the autopsy of PUM II (Pennsylvania University 
Museum), a mummy of unknown age and origin, belong-
ing to an individual believed to have deceased at the age 
of 35–40 years. The embalmed viscera were divided into 
4 packages but only one contained abdominal organs 
such as the spleen and parts of the intestines, while all the 
other 3 contained lung tissue. After rehydration and 
staining the lung tissue, bronchioles, bronchi, cartilage 
and connective tissue were observed. The cellular struc-
ture was partially lost and replaced by nodular or diffuse 
fibrosis. Throughout the fibrotic areas, anthracotic pig-
ment deposits and silica particles were shown to be pre-
dominant: sand pneumoconiosis is indeed the main 
source for fibrotic change. Whether it caused symptoms 
or not was impossible to confidently state, but it support-
ed the hypotheses of inhaling sand during desert storms 
leading to air pollution. Similarly, Tapp et al. [43] inves-
tigated the corpse of a mummy called Nekht-ankh (12th 
Dynasty, Middle Kingdom, ca. 1800 BC). This palaeo-
pathological approach was conducted in the context of 
the well-known interdisciplinary “Manchester Mummy 
Project,” where a catalogue of histological, radiological 
and macroscopically findings of different mummies was 
generated [5]. The content of the jars next to the mummy 
was examined and analyzed: parts of lung tissue in one of 
them were found. Although the mummy itself was in bad 
condition, the extracted organ was well preserved and 
yielded new information on fine particles, especially in 
fibrotic areas and lymphatic tissue around the blood ves-
sels. Ventura et al. (2005) identified human tissue from 4 
canopic jars from one individual, and in 2 of 4 samples, 
they found histological evidence of lung tissue containing 
deposits of anthracotic pigment and silica crystals [44].
Pulmonary Tuberculosis
The earliest references to tuberculosis date back to 
1900 BC in Babylonian and to 1500 BC in Indian texts. 
Later, in the days of Hippocrates, the terms “phthisis” or 
“consumption” were used. A few centuries later, Girola-
mo Fracastoro (1478–1553) mentioned an invisible “vi-
rus” causing the disease. The characteristic lesions were 
named “tubercles” by Sylvius de la Boë of Amsterdam 
(1617–1655). Throughout the following centuries, vari-
ous famous physicians tried to elucidate the physiopa-
thology of this disease, but the first appearance of the 
term “tuberculosis” itself was made in 1834 by the Ger-
man physician Johann Lukas Schönlein of Würzburg 
(1793–1864) [45]. One of the first descriptions of tuber-
culosis by A.J.E. Cave in 1939 dealt with anatomical char-
acteristics of mummified bodies and focused on skeletal 
anomalies [46]. Ruffer and Smith described a case of ex-
trapulmonary tuberculosis in a 3,000-year-old mummy, 
but microscopic proof of bacteria could not be adduced 
[47]. In 1979, Zimmerman unquestionably detected bac-
teria in bone tissue stained with the Ziehl-Neelsen solu-
tion. He also examined lung tissue from the same mum-
my, a 5 year-old child dating from the beginning of Chris-
tian era in Upper Egypt (Coptic 3rd–7th cent. AD) but 
could not detect any bacilli that would have definitely 
proved the occurrence of acute primary tuberculosis [48]. 
Nerlich and colleagues at last were able at last to show 
molecular evidence by investigating lung specimens of a 
mummy dating to the New Kingdom (1550–1080 BC) us-
ing Polymerase chain reaction (PCR) [49]. Donoghue et 
al. investigated lung tissue specimens from Dr. Gran-
ville’s mummy (600 BC), but the organs were still in situ 
and not extracted or embalmed. Nonetheless, histological 
and aDNA analysis were performed showing clear signs 
of Mycobacterium tuberculosis activity, hence confirming 
the coexistence of the pathogen and its host a millennia 
ago [50].
Digestive System (Liver and Gallbladder)
Chronic Cholecystitis and Cholelithiasis
Hippocrates and Aristotle (384–322 BC) had knowl-
edge of biliary diseases, but it was the later Greek physi-
cian and pioneer in the medical sciences in antiquity [51], 
Alexander of Tralles (525–605 AD), who made the first 
accurate description of cholelithiasis in humans relating 
it to the obstruction of the liver. Gentile da Foligno (1272–
1348) mentioned secondary inflammation of the gall 
bladder due to the obstruction of the cystic duct by a gall-
stone for the first time in the 14th century [52]. However, 
Shaw [35] examined the liver and also the gallbladder, 
which was still caudally attached to the liver. The 2.0 cm 
long bladder and 0.1 cm thick wall seem to be normal but 
through microscopic examination Shaw took notice of 
Rokitansky-Aschoff sinuses, a sinking of the mucosal sur-
face reaching into the muscular layer causing no damage 
but believed to be associated with chronic cholecystitis. 
The reason causing the morphology of Rokitansky-As-
choff sinuses is a hyperplasia of epithelial cells and subse-
quent herniation through the fibro-muscular layer. Such 
findings can present asymptomatically in healthy patients 
too. Concerning diseases of the gallbladder in ancient 
preserved bodies, the literature research did not yield fur-
ther information about Egyptian mummies on this mat-
ter, but some data could be found about pre-Columbian 
Chileans in a publication by Munizaga et al. [53]. During 
the examination of the gallbladder of Har-mose simulta-
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neously occurring morphological signs such as fibrosis of 
the wall, hyperaemia, oedema, inflammatory infiltration 
with lymphocytes, plasma cells and granulocytes were not 
described, yet they would be specific for histopathological 
evidence of cholecystitis. These signs were absent due to 
the shrinkage of the soft parts during mummification, 
and therefore, they were not visible. More than a decade 
before Shaw, Smith and Dawson mentioned multiple 
gallstones in a 21st Dynasty mummy with a thin-walled 
gallbladder, not supporting the idea of chronic cholecys-
titis [54]. 
Liver Fibrosis and Cirrhosis 
The term “cirrhosis” was coined by René Laënnec 
originating from the Greek “kirrhos” meaning “tawny 
yellow” [55]. As Ruffer had already predicted in 1910, liv-
er fibrosis and cirrhosis would be shown in the future due 
to his new histological approaches [56]. For example, in 
the case of ROM I, a teenage individual who died of splen-
ic rupture, on whom Reyman et al. [11] performed histo-
logical examination, indistinct hepatic parenchyma but 
clear fibrous patterns typically for liver fibrosis already 
advancing to the stage of early cirrhosis were identified. 
The fact that a young individual was affected by cirrhosis 
leads to the only explanation of schistosomal-caused por-
tal hypertension. This was supported by the findings of 
an infestation of the liver and intestines with calcified 
Schistosoma eggs (cf. Results -1b). It is believed that the 
cirrhosis led to pre-hepatic hypertension and subse-
quently to spleen enlargement and ended up in the rup-
ture of the spleen, which seemed to be the cause of death 
of ROM I [11, 57].
Cardiovascular System
The only case of cardiovascular disease inferred from 
the study of canopic jars is the recent investigation by Bi-
anucci et al. [58] involving radiological, histological and 
genetic examination of tissue specimens found in canopic 
jars of a 3,500-year-old Egyptian mummy. The analysis 
shows pulmonary oedema and bleeding ascribable to acute 
decompensation of a chronic left heart failure, which ulti-
mately led to the individual’s death. It is believed chronic 
hypertension may have been the cause of the failure. More 
knowledge on the palaeopathology of the cardiovascular 
system in Ancient Egypt derives from the study of mum-
mies. The heart was usually left in situ as, according their 
system of belief, it would be weighted against the feather 
of truth in the afterlife. Pathological changes of major arte-
rial vessels have been identified in the form atherosclerosis 
in several élite mummies. Initially, a histological examina-
tion of the vascular tissue, as that implemented by Sir Marc 
A. Ruffer allowed for a certain diagnosis: among the main 
findings is, for example, the demonstration of severe ath-
erosclerosis in the aorta of Pharaoh Merenptah (19th Dy-
nasty), while Shaw demonstrated pathological changes in 
the superior mesenteric artery of the 18th-Dynasty singer, 
Har-mose [59]. Such invasive studies have been substitut-
ed in more recent times by CT examination, culminating 
in the Horus Study, which showed the presence of athero-
sclerotic changes in 20 of 52 analyzed Ancient Egyptian 
mummies [60]. While a certain methodological debate ex-
ists on the accuracy of such radiological finding with sug-
gestions of the necessity to use micro-CT or old-style his-
tology [61, 62], the existence and distribution in the upper 
crust of atherosclerosis in Ancient Egypt have been clari-
fied. Data confirms the information derived from artistic 
and literary evidence [63]. 
Discussion 
It can be seen that canopic jars are not only Egypto-
logically but also medically important. A recent publica-
tion by Sheikoleslami and Ikram, a multidisciplinary 
study of mummies and their corresponding canopic jars 
(including Egyptology and radiology) from the 22nd and 
25th Dynasties, has once more underlined the necessity 
of a holistic approach when assessing this rather peculiar 
bioarchaeological material [64]. 
Canopic jars are filled with viscera such as liver, lungs, 
stomach and intestines, which can all be affected by vari-
ous diseases. While diseases of bones, skin and muscle 
can be verified in mummies, the large number of collect-
ed results and observations clearly speak in favour of the 
unique scientific opportunity represented by canopics 
jars, namely, to study the primary visceral target for many 
a pathogen or condition. The growing impact of canopic 
jars is supported by an increasing number of publications 
on this topic in recent years. Arguably, it is also important 
to determine whether the canopic jars and their contents 
really belong to the mummy buried alongside them in or-
der to clarify the true health status of the corresponding 
individual. This analysis shows that there are more stud-
ies on lungs, liver and intestines available than on stom-
ach tissue. The reasons remain unclear but could be due 
to the rapid decomposition of stomach tissue; therefore, 
it could be more difficult to identify the relevant gastric 
structures. As Grove and colleagues observed in their ap-
proach to the systematical analysis of soft tissue histopa-
thology in palaeopathology, the brain and the kidney 
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have poor conservation potential and are more difficult 
to identify due to the lack of connective tissue and ab-
sence of certain “key structures,” which is instead the case 
of lung and liver tissues [65]. 
The comparison of various studies showed that the ex-
amined tissue is not always in the same condition leading 
to a decrease of visible structures. In some samples, even 
cellular structures like hepatocytes were visible, whereas in 
other studies, this cellular level has not been reached be-
cause of different levels of preservation [28]. The identifi-
cation of diseases and sequencing of pathogens can lead to 
a better understanding of the co-evolution of their hosts 
and their impact on ancient civilisations. In this case, mo-
lecular analysis acts as an enhanced diagnosis that does not 
depends on full histological preservation. Metagenomics 
techniques can, in a single run, characterize the genetic 
material of the host and also of every pathogen present in 
the sample at the moment of death. Both advantages would 
be useful for canopic jar analysis, potentially relating or-
gans from the same individual, thanks to genetic profiling, 
but also in order to screen genetic disorders and patho-
gens, and even more ambitiously, reconstruct whole mi-
crobial communities that live in our body, or microbiome, 
known to be intimately related with abdomen, neural, in-
flammatory and immune conditions [66–69]. Some ap-
plied examples: in a confirmation study performed by Shin 
et al. [70] on a 17th century AD Korean Mummy diag-
nosed with atherosclerotic cardiovascular disease, several 
risk alleles related with the condition were found, indicat-
ing genetic predisposition of the disease. A similar study, 
this time with tuberculosis, in a Hungarian Mummy led to 
characterize 2 different strains of Mycobacterium tubercu-
losis in the same individual who was diagnosed with a ca-
chectic syndrome [71]. Conversely, the above-mentioned 
case of Bianucci et al. [58], studying a canopic jar, did not 
reveal the presence of M. tuberculosis, excluding what 
would otherwise be an erroneous TB diagnose.
On a different track, focusing on the microbiome, var-
ious studies were successful in reconstructing microbial 
communities in South American Mummies [72, 73]; 
much more well-known is Ötzi’s (i.e., the Tyrolean Ice 
Man) gut microbiome retrieved from colon and stomach 
content and whole-genome reconstruction of Helico-
bacter pylori [74, 75]. All of these studies prove that ge-
netic-derived disease, pathogen presence and microbi-
omes can be inferred from mummified soft tissues – in-
cluding canopic jars, when DNA preservation is sufficient.
Furthermore, answers to dynasty-specific clusters of 
disease indicating the nature of an epidemic or how infec-
tious diseases emerged in Ancient Egypt can be found.
Conclusion
For the above-listed reasons, the possibility to shift the 
main focus of paleopathological research to canopic jars 
and mummified viscera may prove a turning point in the 
history of bioarchaeology and retrospective medical diag-
nostics. While until now most studies have concentrated 
on single cases or single canopic jars, an approach target-
ing large series of canopic jars, combining Egyptological 
analysis and biomedical research, is thus suggested as 
most valuable to determine the antiquity and evolution of 
diseases, which still affect mankind [76].
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